Heart rate and respiration monitoring device: performance and usability in patients of all ages
Official title: Study of the Clinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor Cable in Hospital Use
Run by GE Healthcare · NCT07893405 · Data updated 2026-11-12
We’re testing a new physiological monitor to see how well it works and how easy it is to use for patients from newborns to seniors.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | GE Healthcare Industry-sponsored |
| Locations | 1 site (Espoo) |
| Status | Recruiting |
| Started | April 9, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07893405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Hospitals’ patients who can provide informed consent (or have a legal representative) and have ECG data collection feasible in a hospital unit.
✕Probably not a fit
Patients unable to provide consent or those in whom ECG data collection is not feasible or appropriate will not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects ECG and respiration data from participants across age groups to evaluate a new monitoring technology. The goal is to assess performance, usability, and safety in real-world clinical settings. Data will support device development, documentation of safety and performance, and regulatory compliance. No intervention is applied beyond data collection during routine hospital care.
Why it matters
Potential benefit: Participants may contribute to improvements in monitoring technology that could enhance future patient care.
How similar studies have gone: Previous studies in related monitoring technologies have shown feasibility and actionable insights, though results can vary by device.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able to provide written informed consent or have a Legally Designated Representative (LDR) to provide written informed consent; 2. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure; AND 3. ECG can be collected Exclusion Criteria: 1. Are known to be pregnant\* 2. Are breastfeeding; OR, 3. Are suffering from infection(s) or immunocompromised patients that require isolation. 4. PI or caring physician decision due to subject health condition
Where it's running
-
Helsinki University Hospital
Espoo, Finland Recruiting
Study contacts
- Study coordinator: Tero Varpula Principal Investigator
- Email: tero.varpula@hus.fi
- Phone: +35894711
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
-
Easy external landmarks to guide correct esophageal probe placement
This study will test whether simple external body landmarks can reliably tell clinicians how far to insert an esophageal temperature probe in adult ICU patients undergoing TEE.
-
See if 12-lead ECG can predict S-ICD eligibility for adults
This study tests whether a standard 12-lead ECG can predict who is suitable for a subcutaneous defibrillator (S-ICD) before implantation.
-
Bambi Belt heart and breathing monitoring for extremely preterm babies
This project will try using a wireless Bambi Belt to monitor heart rate and breathing in extremely preterm infants under 26 weeks during their first ten days of life.
-
AI-assisted ECG to speed diagnosis and treatment of occlusion heart attacks under a pay-for-performance program
This project will test whether adding an AI tool that flags ECGs for occlusion heart attacks and linking those alerts to a pay-for-performance program helps emergency department patients who get ECGs get diagnosed and treated faster and with better outcomes.
-
AI-ECG alerts to catch early atrial fibrillation risk
This trial tests whether an AI-powered ECG alert can help doctors find people at high risk of developing atrial fibrillation so they can be given continuous heart-rhythm monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.